146 related articles for article (PubMed ID: 8632622)
1. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report.
Teragawa H; Hondo T; Amano H; Watanabe H; Ohe H; Hattori N; Watanabe Y; Hino F; Ohbayashi M
Jpn Heart J; 1996 Jan; 37(1):137-42. PubMed ID: 8632622
[TBL] [Abstract][Full Text] [Related]
2. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
Piazza M; Orlando R; Tosone G; Tiseo D; Conte MC; Minervini F; Santoro G; Scordino F; Vitale D
Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
[TBL] [Abstract][Full Text] [Related]
4. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
[No Abstract] [Full Text] [Related]
5. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
Veerabagu MP; Finkelstein SD; Rabinovitz M
Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
Maeda T; Onishi S; Miura T; Iwamura S; Tomita A; Saibara T; Yamamoto Y
Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
[TBL] [Abstract][Full Text] [Related]
7. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.
Colombo M; Lampertico P; Rumi M
Gut; 1993; 34(2 Suppl):S141. PubMed ID: 8314483
[TBL] [Abstract][Full Text] [Related]
8. Sarcoidosis after interferon therapy for chronic active hepatitis C.
Teragawa H; Hondo T; Takahashi K; Watanabe H; Ohe H; Hattori N; Watanabe Y; Amano H; Hino F; Ohbayashi M; Urushihara T; Yonehara S
Intern Med; 1996 Jan; 35(1):19-23. PubMed ID: 8652926
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
[TBL] [Abstract][Full Text] [Related]
10. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
Tada H; Saitoh S; Nakagawa Y; Hirana H; Morimoto M; Shima T; Shimamoto K; Okanoue T; Kashima K
J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
[TBL] [Abstract][Full Text] [Related]
11. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
Chin K; Tabata C; Sataka N; Nagai S; Moriyasu F; Kuno K
Chest; 1994 Mar; 105(3):939-41. PubMed ID: 8131569
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
[TBL] [Abstract][Full Text] [Related]
13. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
[No Abstract] [Full Text] [Related]
14. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
[TBL] [Abstract][Full Text] [Related]
15. Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.
Villa E; Trande P; Grottola A; Buttafoco P; Rebecchi AM; Stroffolini T; Callea F; Merighi A; Camellini L; Zoboli P; Cosenza R; Miglioli L; Loria P; Iori R; Carulli N; Manenti F
Dig Dis Sci; 1996 Jun; 41(6):1241-7. PubMed ID: 8654159
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
[TBL] [Abstract][Full Text] [Related]
17. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
[No Abstract] [Full Text] [Related]
18. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
Núñez M; Miralles ES; de las Heras ME; Ledo A
J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
[No Abstract] [Full Text] [Related]
19. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
[No Abstract] [Full Text] [Related]
20. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
Fernández I; Castellano G; Canga F; Colina F; García H; Fuertes A; Casis B; Martín A; Solís JA
Gastroenterol Hepatol; 1995 Feb; 18(2):66-72. PubMed ID: 7621277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
